Becton Dickinson and Co vs Raymond James Financial, Inc. — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Raymond James Financial, Inc. trades at $180.02 (market cap $34.63B). The key difference: Becton Dickinson and Co is the larger of the two by market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| BDX | RJF | |
|---|---|---|
Market Cap | $49.41B | $34.63B |
Sector | Health | Financials |
52-Week High | $185.39 | $180.55 |
52-Week Low | $138.62 | $140.89 |
Enterprise Value | $65.51B | — |
Dividend Yield | 2.32% | 1.2% |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →